By NOF; Saturday, April 28, 2012

The National Osteoporosis Foundation Announces Winner of the Second Annual Lawrence G. Raisz Memorial Lecture Award

The nation’s top osteoporosis researchers and clinicians will gather in Orlando, Florida this week for the National Osteoporosis Foundation’s (NOF) International Symposium on Osteoporosis (ISO12): Translating Research into Clinical Practice. Held annually, the meeting is the premier scientific event entirely dedicated to the treatment and study of osteoporosis and aims to close the gap between osteoporosis research and its application in clinical practice. As the 2012 recipient of the Lawrence G. Raisz, MD Memorial Lecture Award, Robert Lindsay, M.D., PhD, Chief of Internal Medicine at Helen Hayes Hospital, Past President and long-term NOF Board of Trustees member will present Skeletal Health in Osteoporosis: Past, Present & Future to kickoff the meeting’s opening session at 8:00am on Thursday, April 26.

Dr. Robert Lindsay to Kickoff NOF’s International Symposium on Osteoporosis (ISO12): Translating Research Into Clinical Practice Thursday, April 26 at the Peabody Hotel Orlando

Washington, D.C. April 24, 2012 – The nation’s top osteoporosis researchers and clinicians will gather in Orlando, Florida this week for the National Osteoporosis Foundation’s (NOF) International Symposium on Osteoporosis (ISO12): Translating Research into Clinical Practice. Held annually, the meeting is the premier scientific event entirely dedicated to the treatment and study of osteoporosis and aims to close the gap between osteoporosis research and its application in clinical practice.

As the 2012 recipient of the Lawrence G. Raisz, MD Memorial Lecture Award, Robert Lindsay, M.D., PhD, Chief of Internal Medicine at Helen Hayes Hospital, Past President and long-term NOF Board of Trustees member will present Skeletal Health in Osteoporosis: Past, Present & Future to kickoff the meeting’s opening session at 8:00am on Thursday, April 26. Dr. Lindsay will lead session participants on a journey from the early years of osteoporosis management when the only treatment available was estrogen and nearly all patients presented with fractures to the diagnostic and therapeutic advancements that have been made since and a preview of what’s to come.

“We are thrilled to have Dr. Lindsay open this year’s ISO with a look at the accomplishments we’ve made in better treating and diagnosing osteoporosis, but with osteoporosis causing an estimated two million fractures every year, we’re all focused on what’s to come as the condition remains significantly under-diagnosed and under-treated,” said Amy Porter, executive director and CEO, National Osteoporosis Foundation. “With the work researchers like Dr. Lindsay are doing every day, this is an exciting time in the osteoporosis field. Also as a top clinician, he embodies what we hope to accomplish through the ISO – that all attendees gain new information and insights they can apply in clinical practice to better treat and diagnose patients immediately following the conference.”

Named in honor of the late Lawrence G. Raisz, MD, the Lawrence G. Raisz, MD Memorial Lecture Award recognizes a clinical scientist who is dedicated to the prevention, diagnosis and treatment of osteoporosis and has made a significant contribution to the osteoporosis and bone metabolism field of study. As a longtime member of NOF’s Board of Trustees and the organization’s Vice President, Dr. Raisz’ service to NOF was extensive and invaluable.

He served as Chair of NOF’s first Scientific Advisory Board and subsequently was appointed a member of the Board of Trustees. While serving as NOF Vice President, Dr. Raisz chaired the Science and Research Committee and worked hard to raise awareness of osteoporosis and metabolic bone diseases among physicians and the public. His unwavering dedication to scientific excellence and patient care helped shape NOF's mission and programs of outreach and education. The investment Dr. Raisz made in the next generation of physician-scientists has helped ensure the continued growth and success of the osteoporosis and bone metabolism field.

Dr. Lindsay’s long-standing commitment to advancing osteoporosis care and treatment makes him a natural follower of the example set by Dr. Raisz and the leading choice to receive NOF’s prestigious award. Dr. Lindsay serves as the co-editor of NOF’s world class journal, Osteoporosis International and throughout his career, has authored more than 300 journal articles, abstracts, and book chapters on osteoporosis and estrogen replacement therapy. He was awarded the Bartter Award for excellence in clinical research in 1997 by the American Society for Bone and Mineral Research and was the recipient of NOF’s 1999 Scientific Leadership Award.

In addition to Dr. Lindsay’s opening session, ISO12 offers a comprehensive educational program covering all aspects of osteoporosis patient management, including innovative and cutting edge sessions presented by world class experts to help meet today’s clinical challenges. The pain and suffering caused by osteoporosis can be largely prevented through proper prevention, diagnosis and treatment. The information shared at ISO12 will provide clinicians with the most current data and practical application to prevent osteoporosis by more accurately identifying those at risk and better diagnosing and treating those with the disease.

 

About the National Osteoporosis Foundation
Established in 1984, the National Osteoporosis Foundation, a leading community-focused health organization, is dedicated to the prevention of osteoporosis and broken bones, the promotion of strong bones for life and the reduction of human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit www.nof.org.

The latest

The National Osteoporosis Foundation has named Barbara Hannah Grufferman as its first Bone Health Ambassador. In this newly-established role, Grufferman, a well-known advocate for healthy and positive living, will dedicate her time, talent and energy to raise awareness for osteoporosis and the importance of building strong bones for life.

Thanks to a generous gift from The Samuel J. & Ethel LeFrak Charitable Trust, the National Osteoporosis Foundation met its Generations of Strength fundraising goal one year early. NOF launched the Generations of Strength initiative in September 2011 with the goal of raising $2 million in two years to improve patient care for the most vulnerable – those who have broken bones due to osteoporosis – and to protect future generations from the disease.

The National Osteoporosis Foundation (NOF), the nation’s leading health organization dedicated to preventing osteoporosis and broken bones, has named Claire Gill as its Senior Director of Marketing, Consumer and Corporate Outreach.  Gill brings extensive experience in public relations and marketing communications to this newly-established role.